COHERUS BIOSCIENCES INC. - COMMON STOCK

Coherus BioSciences to Report Third Quarter 2023 Financial Results on November 6, 2023

30 10 2023 17:00:00 提供 Nasdaq GlobeNewswire

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

27 10 2023 14:07:20 提供 Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

24 10 2023 18:41:27 提供 Nasdaq GlobeNewswire

Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

14 10 2023 11:30:00 提供 Nasdaq GlobeNewswire

Coherus Announces Resubmission of Biologics License Application (BLA) Supplement for UDENYCA® ONBODY™

05 10 2023 07:30:00 提供 Nasdaq GlobeNewswire

CIMERLI® (ranibizumab-eqrn) Sales Exceed 100,000 Doses in First Year of Launch

04 10 2023 07:30:00 提供 Nasdaq GlobeNewswire

Coherus Applauds Congressional Designation of September 30th as Rare Cancer Day

02 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

Coherus Announces Three Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

27 9 2023 08:10:29 提供 Nasdaq GlobeNewswire

FDA Issues Complete Response Letter (CRL) for UDENYCA® ONBODY™ Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-Party Filler; Coherus Also Announces Completion of Toripalimab FDA Inspections

25 9 2023 07:30:00 提供 Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

22 9 2023 20:00:00 提供 Nasdaq GlobeNewswire

Coherus Completes Surface Oncology Acquisition

08 9 2023 08:05:40 提供 Nasdaq GlobeNewswire

Coherus BioSciences to Participate at Upcoming September Investor Conferences

01 9 2023 15:01:00 提供 Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

22 8 2023 16:35:22 提供 Nasdaq GlobeNewswire

Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights

02 8 2023 15:01:00 提供 Nasdaq GlobeNewswire

Coherus BioSciences to Report Second Quarter 2023 Financial Results on August 02, 2023

26 7 2023 15:05:00 提供 Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

21 7 2023 16:30:00 提供 Nasdaq GlobeNewswire

Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors

20 7 2023 15:04:53 提供 Nasdaq GlobeNewswire

Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™

13 7 2023 07:30:00 提供 Nasdaq GlobeNewswire

Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.

03 7 2023 07:30:00 提供 Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

26 6 2023 20:08:00 提供 Nasdaq GlobeNewswire